Kangmei Pharmaceutical Co., Ltd. (SHA:600518)

Kangmei Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	167.34	977.84	1,057	1,507	2,419	552.34
Trading Asset Securities	0.08	0.08	0.08	0.12	0.52	-
Cash & Short-Term Investments	167.42	977.92	1,057	1,508	2,419	552.34
Cash Growth	-77.52%	-7.45%	-29.90%	-37.68%	337.98%	8.93%
Accounts Receivable	1,915	2,391	2,095	2,046	1,460	2,487
Other Receivables	10,213	659.16	874.44	888.79	1,052	9,559
Receivables	12,128	3,050	2,969	2,935	2,512	12,046
Inventory	606.86	2,510	2,644	2,751	3,195	5,709
Prepaid Expenses	-	-	0.69	0	-	0.01
Other Current Assets	161.71	361.87	139.28	190.85	158.8	234.39
Total Current Assets	13,064	6,900	6,810	7,384	8,285	18,541
Property, Plant & Equipment	1,047	3,500	3,875	4,180	4,642	9,603
Long-Term Investments	2,565	1.11	1.15	1.39	1	1
Goodwill	-	106.35	106.35	106.35	106.35	36.91
Other Intangible Assets	178.4	409.47	491.02	529.79	579.73	1,309
Long-Term Deferred Tax Assets	21.23	74.36	101.48	96.97	60.69	240.96
Long-Term Deferred Charges	36.24	55.05	66.47	86.71	110.22	111.57
Other Long-Term Assets	33.34	2,752	2,829	2,783	2,269	3,483
Total Assets	16,945	13,798	14,280	15,169	16,054	33,326
Accounts Payable	1,270	2,546	2,256	2,563	2,015	3,762
Accrued Expenses	29.98	66.58	873.71	1,328	1,134	2,066
Short-Term Debt	-	15.83	26.14	25.62	15.17	2,315
Current Portion of Long-Term Debt	-	28.35	-	-	-	-
Current Portion of Leases	-	-	40.71	39.12	36.89	-
Current Income Taxes Payable	-	418.04	24.74	26.2	140.5	112.15
Current Unearned Revenue	27.55	118.82	159.89	158.12	193.85	455.19
Other Current Liabilities	3,445	2,700	1,298	1,301	1,411	14,576
Total Current Liabilities	4,772	5,894	4,680	5,442	4,947	23,286
Long-Term Debt	-	-	-	-	-	19,415
Long-Term Leases	66.62	94.95	188.16	199.13	153.22	-
Long-Term Unearned Revenue	78.49	555.78	618.68	653.98	692.97	1,035
Long-Term Deferred Tax Liabilities	19.17	26.85	51.68	55.53	-	0.05
Other Long-Term Liabilities	4.1	17.79	1,661	1,835	293.02	-
Total Liabilities	4,941	6,589	7,200	8,185	6,086	43,736
Common Stock	13,864	13,864	13,864	13,864	13,864	4,974
Additional Paid-In Capital	-	18,783	18,783	18,783	18,783	11,576
Retained Earnings	-19,621	-24,367	-24,375	-24,478	-21,790	-29,706
Treasury Stock	-1,107	-1,107	-1,225	-1,222	-932.82	-343.6
Comprehensive Income & Other	18,868	1.18	1.18	1.43	3.1	-3.74
Total Common Equity	12,005	7,174	7,048	6,948	9,927	-13,504
Minority Interest	-	34.55	32.89	35.43	41.92	126.47
Shareholders' Equity	12,005	7,209	7,080	6,984	9,968	-10,410
Total Liabilities & Equity	16,945	13,798	14,280	15,169	16,054	33,326
Total Debt	66.62	139.13	255.01	263.87	205.29	21,730
Net Cash (Debt)	100.8	838.8	801.68	1,244	2,214	-21,178
Net Cash Growth	-79.38%	4.63%	-35.54%	-43.82%	-	-
Net Cash Per Share	0.01	0.06	0.08	0.09	0.16	-1.53
Filing Date Shares Outstanding	8,506	-	13,864	13,864	13,864	4,974
Total Common Shares Outstanding	8,506	-	13,864	13,864	13,864	4,974
Working Capital	8,292	1,007	2,130	1,942	3,338	-4,745
Book Value Per Share	1.41	-	0.51	0.50	0.72	-2.71
Tangible Book Value	11,826	6,658	6,450	6,312	9,240	-14,849
Tangible Book Value Per Share	1.39	-	0.47	0.46	0.67	-2.99
Buildings	-	-	5,229	5,401	5,665	8,359
Machinery	-	-	820.08	826.65	1,206	2,799
Construction In Progress	-	-	210.56	215.5	263.65	1,630

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.